BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8119458)

  • 1. Cervical koilocytosis and high risk HPV types: the benefit of laser vaporization.
    Hørding U; Rygaard C; Ruge S; Felding C; Lundvall F; Junge J
    Eur J Obstet Gynecol Reprod Biol; 1993 Oct; 51(2):125-30. PubMed ID: 8119458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CO2 laser vaporization in the treatment of cervical human papillomavirus infection in women with abnormal Papanicolaou smears.
    Ruge S; Felding C; Skouby SO; Lundvall F; Hørding U; Norrild B
    Gynecol Obstet Invest; 1992; 33(3):172-6. PubMed ID: 1319385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of laser vaporization in the management of cervical intraepithelial neoplasia associated with human papilloma virus infection.
    Woodman CB; Byrne P; Kelly KA; Hilton C
    J Public Health Med; 1993 Dec; 15(4):327-31. PubMed ID: 7864916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryotherapy and CO2-laser vaporization in the treatment of cervical and vaginal human papillomavirus (HPV) infections.
    Yliskoski M; Saarikoski S; Syrjänen K; Syrjänen S; Castrén O
    Acta Obstet Gynecol Scand; 1989; 68(7):619-25. PubMed ID: 2561042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of HPV testing in the follow-up of women treated for cervical dysplasia.
    Ribaldone R; Boldorini R; Capuano A; Arrigoni S; Di Oto A; Surico N
    Arch Gynecol Obstet; 2010 Aug; 282(2):193-7. PubMed ID: 20012636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of 'high-risk' cervical papillomavirus infection by biopsy morphology.
    Franquemont DW; Ward BE; Andersen WA; Crum CP
    Am J Clin Pathol; 1989 Nov; 92(5):577-82. PubMed ID: 2554717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human papillomavirus infections of the cervix uteri. Clinical implications, indications of typing].
    Laval C; Le Doussal V; Pratili M
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(7):803-10. PubMed ID: 2177486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic sensitivity of polymerase chain reaction and Southern blot hybridization for the detection of human papillomavirus DNA in biopsy specimens from cervical lesions.
    Tham KM; Chow VT; Singh P; Tock EP; Ching KC; Lim-Tan SK; Sng IT; Bernard HU
    Am J Clin Pathol; 1991 May; 95(5):638-46. PubMed ID: 1850950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of multiple types of human papillomavirus in genital tract lesions. Analysis by in situ hybridization and the polymerase chain reaction.
    Nuovo GJ; Darfler MM; Impraim CC; Bromley SE
    Am J Pathol; 1991 Jan; 138(1):53-8. PubMed ID: 1846265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
    Nagai N
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new nonisotopic detection of human papillomavirus DNA using polymerase chain reaction.
    Binninger I; Clavel C; Polette M; Boutterin MC; Chypre C; Alpha B; Birembaut P
    Diagn Mol Pathol; 1992 Dec; 1(4):239-45. PubMed ID: 1342972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometric assessment of the biological potential of human papillomavirus infections in the uterine cervix.
    Tosi P; Luzi P; Santopietro R; Miracco C; Lio R; Syrjänen S; Mäntyjärvi R; Syrjänen K
    Appl Pathol; 1988; 6(4):247-57. PubMed ID: 2846018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of different types of human papillomavirus in cervical infection of north Italian women.
    Garuti G; Boselli F; Genazzani A; Genazzani AR
    Eur J Obstet Gynecol Reprod Biol; 1991 May; 39(3):227-33. PubMed ID: 1851706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diathermic loop treatment of subclinical cervical infection by human papilloma virus (HPV). Short-term effectiveness].
    Milla Villeda RH; Gurrola Medrano T
    Ginecol Obstet Mex; 1995 Jul; 63():293-6. PubMed ID: 7665115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative test performance of dot filter hybridization (Viratype) and conventional morphologic analysis to detect human papillomavirus.
    Weintraub J; Redard M; Seydoux J
    Am J Clin Pathol; 1992 Jan; 97(1):46-57. PubMed ID: 1309483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of HPV DNA in the uterine cervical lesions by polymerase chain reaction and in situ hybridization].
    Kyo S; Inoue M; Nakazawa A; Ogawa H; Ueda G; Tanizawa O
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):541-8. PubMed ID: 1647430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polymerase chain reaction in detection of human papillomavirus DNA in esophageal carcinoma].
    Chen BF
    Zhonghua Yi Xue Za Zhi; 1993 Nov; 73(11):667-9, 701. PubMed ID: 8124615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical aspects of HPV-16/18 associated cervical lesions].
    Göppinger A; Birmelin G; Hauser U; Ikenberg H
    Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):106-9. PubMed ID: 2156746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.